Global Biologics CDMO Services Supply, Demand and Key Producers, 2024-2030

Global Biologics CDMO Services Supply, Demand and Key Producers, 2024-2030

The global Biologics CDMO Services market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Biologics CDMO Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biologics CDMO Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics CDMO Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Biologics CDMO Services total market, 2019-2030, (USD Million)

Global Biologics CDMO Services total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Biologics CDMO Services total market, key domestic companies and share, (USD Million)

Global Biologics CDMO Services revenue by player and market share 2019-2024, (USD Million)

Global Biologics CDMO Services total market by Type, CAGR, 2019-2030, (USD Million)

Global Biologics CDMO Services total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Biologics CDMO Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific and AGC Biologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics CDMO Services market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Biologics CDMO Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biologics CDMO Services Market, Segmentation by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other

Global Biologics CDMO Services Market, Segmentation by Application
SMBs
Large Companies

Companies Profiled:
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals

Key Questions Answered

1. How big is the global Biologics CDMO Services market?

2. What is the demand of the global Biologics CDMO Services market?

3. What is the year over year growth of the global Biologics CDMO Services market?

4. What is the total value of the global Biologics CDMO Services market?

5. Who are the major players in the global Biologics CDMO Services market?